Publications by authors named "Adalbert WeiSSmann"

Claim this Profile
I
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.
Arnold Bolomsky, Wolfgang Hübl, Stefano Spada, Ercan Müldür, Karin Schlangen

Am J Hematol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.
Heinz Ludwig, Elisabeth Rauch, Thomas Kuehr, Zdeněk Adam, Adalbert Weißmann

Haematologica· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Heinz Ludwig, Hedwig Kasparu, Clemens Leitgeb, Elisabeth Rauch, Werner Linkesch

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.
Matthias Pinter, Wolfgang Sieghart, Ivo Graziadei, Wolfgang Vogel, Andreas Maieron, Adalbert Weissmann

Oncologist· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis